Incidence of melanoma and keratinocyte (nonmelanoma) skin cancers, such as squamous cell and basal cell carcinomas (SCC and BCC, respectively), continues to increase, but mortality rates are stable or declining because of an explosion of treatment options, including numerous immunotherapy regimens, according to an oral presentation at the 2024 Oncology Nurse Advisor Summit.
Melanoma News
AI-based app can help physicians find skin melanoma
A mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This is demonstrated by a national study involving researchers from the University of Gothenburg. For the study, the app has been tested in clinical practice at primary care centers.
Perlmutter Cancer Center Clinical Trial Tests Personalized mRNA Vaccine for Treating Metastatic Melanoma
Vaccines developed using mRNA technology helped turn the tide during the COVID-19 pandemic. Now, researchers at NYU Langone Health’s Perlmutter Cancer Center and other cancer centers around the world are looking at using mRNA vaccines to personalize cancer treatment.
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.